ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Wells Fargo Cuts Zimmer Biomet Holdings to Underweight From Equalweight; Price Target to $124 From $170

01/19/2022 | 08:18am EDT


© MT Newswires 2022
All news about ZIMMER BIOMET HOLDINGS
05/19ZIMMER BIOMET HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
05/17Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $125 From $135, Maintains N..
MT
05/17Zimmer Biomet Holdings Maintains Dividend at $0.24/Share; Payable on July 29 to Shareho..
MT
05/17Zimmer Biomet Holdings, Inc. Approves Quarterly Dividend for Second Quarter of 2022, Pa..
CI
05/16ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD Di..
AQ
05/16Zimmer Biomet Holdings, Inc. Appoints Paul Stellato as Controller and Chief Accounting ..
CI
05/11Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni Su..
AQ
05/10Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni&tr..
PR
05/10Zimmer Biomet Holdings, Inc. Debuts First-Of-Its-Kind Artificial Intelligence Capabilit..
CI
05/05ZIMMER BIOMET HOLDINGS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS
More recommendations
Financials (USD)
Sales 2022 6 836 M - -
Net income 2022 735 M - -
Net Debt 2022 5 053 M - -
P/E ratio 2022 36,6x
Yield 2022 0,83%
Capitalization 24 648 M 24 648 M -
EV / Sales 2022 4,34x
EV / Sales 2023 4,03x
Nbr of Employees 19 500
Free-Float 63,2%
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 117,61 $
Average target price 132,27 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Ivan Tornos Chief Operating Officer
Angela Main Chief Compliance Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS-5.52%24 648
ABBOTT LABORATORIES-19.54%198 277
MEDTRONIC PLC-0.89%137 548
BECTON, DICKINSON AND COMPANY2.66%71 922
HOYA CORPORATION-22.41%37 902
BAXTER INTERNATIONAL INC.-14.69%36 873